期刊文献+

缓释药物的研究进展及临床应用 被引量:1

Research progress and clinical application of sustained-release drugs
在线阅读 下载PDF
导出
摘要 背景:各种制备缓释制剂的缓释材料很多,目前可用于生产的缓释材料有40多种,广泛应用于临床多种疾病的治疗。目的:对目前国内外几种重要的缓释药物载体材料及临床上常用的缓释药物进行总结。方法:应用计算机检索CNKI和PubMed数据库2000-01/2010-12关于缓释药物研究的文章,在标题和摘要中以"缓释,药物,生物材料"或"sustained release,drug,biomaterials"为检索词进行检索。选择文章内容与缓释药物密切相关的文章。排除Meta分析及重复性研究,最终纳入23篇文献进入结果分析。结果与结论:可生物降解的合成高分子材料受到普遍重视并得到广泛应用,壳聚糖以其良好的性能备受青睐,成为药物缓释的一种重要载体,生物降解高分子聚乳酸在药物缓释方面的应用,起到重要的治疗作用;纤维蛋白胶生物相容性高,能有效延缓药物释放,在临床很多领域广泛应用。 BACKGROUND:Currently,there are over 40 kinds of slow-release materials available for the production,which are widely used in clinic.OBJECTIVE:To review several important drug carrier materials in the world as well as sustained-release drugs commonly used in clinic.METHODS:A computer search of CNKI and PubMed databases(2000-01/2010-12) were conducted for articles addressing sustained-release drugs.The keywords were "sustained release,drug,biomaterials" in Chinese and English.Meta analysis and repetitive studies were excluded.Finally,23 articles were included in result analysis.RESULTS AND CONCLUSION:Biodegradable synthetic polymer materials have become highly valued and widely used.Chitosan has become widely accepted for its good performance,as an important carrier of drug delivery;polylactic acid,a biodegradable polymer,plays an important treatment role in drug delivery;fibrin glue with high biocompatibility can effectively delay the drug release,which is widely used in many clinical areas.
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2011年第38期7193-7196,共4页 Journal of Clinical Rehabilitative Tissue Engineering Research
  • 相关文献

参考文献23

  • 1Altankov G,Groth T.Fibronectin matrix formation by human fibroblasts on surfaces varying in wettability.J Biomater Sci Polym Ed.1996;8(4):299-310.
  • 2Ludwig A.The use of mucoadhesive polymers in ocular drug delivery.Adv Drug Deliv Rev.2005;57(11):1595-1639.
  • 3Coviello T,Matricardi P,Marianecci C,et al.Polysaccharide hydrogels for modified release formulations.J Control Release.2007;119(1):5-24.
  • 4廖戎.聚乳酸微球制备的初步研究[J].西南民族大学学报(自然科学版),2006,32(1):84-87. 被引量:6
  • 5佟铭,韩雅玲,王冬梅,王翎,许凤芝,王耿.琥珀酸美托洛尔缓释片治疗高血压的降压疗效及安全性评价[J].解放军保健医学杂志,2008,10(1):59-60. 被引量:6
  • 6Rokhade AP,Patil SA,Aminabhavi TM.Synthesis and characterization of semi-interpenetrating polymer network microspheres of acrylamide grafted dextran and chitosan for controlled release of acyclovir.Carbohydrate Polymers.2007;67(4):605-613.
  • 7Zhang H,Alsarra IA,Neau SH.An in vitro evaluation of a chitosan-containing multiparticulate system for macromolecule deliveryto the colon.Int J Pharm.2002;239(1/2):197-205.
  • 8Al-Musa S,Abu Fara D,Badwan AA.Evaluation of parameters involved in preparation and release of drug loaded in crosslinked matrices of alginate.J Control Release.1999;57(3):223-232.
  • 9Sah H,Chien YW.Effects of H+ liberated from hydrolytic cleavage of polyester microcapsules on their permeability and degradability.J Pharm Sci.1995;84(11):1353-1359.
  • 10Crow BB,Nelson KD.Release of bovine serum albumin from a hydrogel-cored biodegradable polymer fiber.Biopolymers.2006;81(6):419-427.

二级参考文献95

共引文献62

同被引文献21

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部